SPARK-CGM: Boosting CGM Use in Primary Care
Official title: Supporting Primary Care Adoption, Resources, and Knowledge for Continuous Glucose Monitoring
Run by Montefiore Medical Center · NCT07548372 · Data updated 2026-11-12
This program tests whether a multi-component package can help primary care clinics prescribe continuous glucose monitoring more often for adults with diabetes on insulin.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Montefiore Medical Center Academic / other |
| Locations | 1 site (The Bronx, New York) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | May 2028 |
| Study ends | May 2028 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT07548372 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with diabetes treated with insulin receiving care at participating Montefiore primary care sites, and staff involved in CGM prescribing and education.
✕Probably not a fit
Patients not eligible for CGM (e.g., not on insulin or not seen at participating sites) may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
SPARK-CGM is a hybrid effectiveness-implementation project that provides education, streamlined prescribing, insurance workflows, and staff training to increase new CGM prescriptions in adult diabetes patients treated with insulin at Montefiore primary care sites. The study uses a stepped-wedge cluster randomized design, where clinics gradually transition from usual care to the SPARK-CGM approach over time. The goal is to see if the intervention improves CGM uptake, reduces administrative barriers, and supports better glycemic management in real-world primary care settings. Outcomes include prescribing rates and integration of CGM workflows across clinics and providers.
Why it matters
Potential benefit: If successful, patients could access CGM more readily, potentially improving blood sugar control and quality of life.
How similar studies have gone: Previous efforts to implement CGM in primary care have shown promise when workflow and education barriers are addressed, though this exact multi-component, stepped-wedge approach is developing the evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Clinic level: * All adult Montefiore primary care sites * Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff Patient level: * Age 18 years or older * Receive primary care at participating sites * Diagnosis of any diabetes mellitus * Treated with insulin therapy Exclusion Criteria: Clinic level: \- Sites participating in pilot phase of CGM initiative Patient level: \- Existing CGM prescription within 24 months before the study start
Where it's running
-
Montefiore Medical Group (MMG)
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Jovan Milosavljevic, MD — Montefiore Medical Center
- Study coordinator: Rosina Antwi
- Email: rosina.antwi@einsteinmed.edu
- Phone: 646-515-8399
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.